Evidence map›Paper›PMID 40180932›Full record

ArticleNature communications2025

Pathogenic mutation impairs functional dynamics of Hsp60 in mono- and oligomeric states.

Luca Torielli, Federica Guarra, Hao Shao, Jason E Gestwicki, Stefano A Serapian, Giorgio Colombo

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Luca Torielli *Department of Chemistry, University of Pavia, Pavia, Italy.
Federica Guarra *Department of Chemistry, University of Pavia, Pavia, Italy.ORCID http://orcid.org/0000-0002-7301-3000
Hao ShaoDepartment of Pharmaceutical Chemistry and the Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA, USA.
Jason E GestwickiDepartment of Pharmaceutical Chemistry and the Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-6125-3154
Stefano A SerapianDepartment of Chemistry, University of Pavia, Pavia, Italy. stefanoartin.serapian@unipv.it.ORCID http://orcid.org/0000-0003-0122-8499
Giorgio ColomboDepartment of Chemistry, University of Pavia, Pavia, Italy. g.colombo@unipv.it.ORCID http://orcid.org/0000-0002-1318-668X

Funding

Molecular Chaperones and Small MoleculesR01NS059690 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Jason E Gestwicki · 2008 to 2026
$7.9M
Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) IG 2022 - ID 27139Ministero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research) PRIN grant 20209KYCH9NINDS NIH HHS R01 NS059690
6 · The paper itself

Abstract

Mitochondrial chaperonin Heat Shock Protein 60 kDa (Hsp60) oversees the correct folding of client proteins in cooperation with Hsp10. Hsp60 monomers M first form 7-meric Single rings (S), which then pair into 14-meric Double rings (D) that accommodate clients in their lumen. Recruitment of 7 Hsp10 molecules per pole yields a sealed 28-meric Football-shaped complex (F). ATP hydrolysis in each Hsp60 unit drives client folding and F disassembly. The V72I mutation in hereditary spastic paraplegia form SPG13 impairs Hsp60 function despite being distant from the active site. We here investigate this impairment with atomistic molecular dynamics (MD) simulations of M, S, D, and F for both WT and mutant Hsp60, considering catalytic aspartates in D and F in different protonation states (even simulating one such state of D post-hydrolysis). Our findings show that-as observed experimentally-V72I rigidifies Hsp60 assemblies, significantly impacting internal dynamics. In monomers, V72I introduces a new allosteric route that bypasses the ATP binding site and affects mechanisms driving reactivity. These insights highlight a multiscale complexity of Hsp60 that could inspire the design of experiments to better understand both its WT and V72I variants.

Indexed as

Chaperonin 60Mitochondrial ProteinsMutationProtein MultimerizationComputer SimulationHumansModels, MolecularProtein Structure, QuaternaryProtein Structure, TertiaryChaperonin 60HSPD1 protein, humanMitochondrial Proteins

Identifiers

PMID40180932
PMCPMC11968893

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.